As of 14 Oct 2026, Caris Life Sciences has raised $168M across 1 verified round on record; latest: $168 million growth round led by Braidwell, announced 7 Apr 2025.
Caris Life Sciences sells precision oncology solutions including molecular profiling tests and data analytics for cancer detection and treatment.
carislifesciences.comLinkedInPublic company
1 source
The release also states that Caris has raised $1.86 billion in capital since 2018; this is cumulative capital, not the round amount.; not on the page it cites, so not applied: headquarters
Published by hand (carislifesciences.com): "Caris Life Sciences announced today that the company has closed a growth capital funding round of $168 million.": biggest-rounds completeness (K): hand-checked, the cited page states $168 million
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Growth growth capital funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $168M $1.9B to date | 2025-04-07 | Braidwell | No recent discussion |
1 source [ VERIFIED · CORRECTED ] read against 1 source
The release also states that Caris has raised $1.86 billion in capital since 2018; this is cumulative capital, not the round amount.; not on the page it cites, so not applied: headquarters Published by hand (carislifesciences.com): "Caris Life Sciences announced today that the company has closed a growth capital funding round of $168 million.": biggest-rounds completeness (K): hand-checked, the cited page states $168 million | ||||